| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6177500 | European Urology | 2016 | 9 Pages |
Abstract
The androgen-inactivating UGT2B28 enzyme influences hormone levels, clinical and pathologic factors, and the risk of cancer progression.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Anaïs Belledant, Hélène Hovington, Luciana Garcia, Patrick Caron, Hervé Brisson, Lyne Villeneuve, David Simonyan, Bernard Têtu, Yves Fradet, Louis Lacombe, Chantal Guillemette, Eric Lévesque,